Genes play a critical, yet not fully understood role in multiple sclerosis (MS). While not directly inherited, certain genetic variations can increase a person's susceptibility to developing MS. Understanding the role of genetics and epigenetics is vital for unravelling more about MS, how MS progresses and how we can optimise treatment.
In this webinar, Dr Vicki Maltby provides an overview of genetics and epigenetics and their relevance to MS, she also touches on:
- The likelihood of developing MS and family studies
- Genetic links to progression
- Recent research into the Yamnaya people and people of Northern European descent
- Environmental and lifestyle factors, and how genetics plays a role in risk of developing MS
- Epstein-Barr Virus (EBV) and biological aging in MS
- Epigenetics and how this may influence treatment decisions
Presenter
Dr. Maltby completed her PhD in molecular epigenetics at the University of British Columbia in Vancouver, Canada. She moved to Newcastle as a research fellow in 2012 and is not a Research fellow at the John Hunter Hospital and a Conjoint Senior Lecturer at the University of Newcastle. Her research focus is on identification of epigenetic factors involved in multiple sclerosis. Her group has characterised the genome wide epigenetic changes in various immune cells involved in Multiple Sclerosis.
Published April 2024



